Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency: Guidance for Industry

Topics:COVID-19

The US FDA has published recommendations for maintaining data integrity in clinical trials during the SARS-COVID 19 emergency response period.
Read the recommendations here